The renin-angiotensin system in the rabbit eye

Journal of Ocular Pharmacology and Therapeutics

Volumn 12, Issue 3, 1996, Pages 299-312

  Ramirez, Manuel ^a   Davidson, Elizabeth A ^a   Luttenauer, Laurent ^a   Elena, Pierre Paul ^b   Cumin, Frédéric ^a   Mathis, Georg A ^c   De Gasparo, Marc ^a,d  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b Iris Pharma   (France)

^c CIBA Vision Ophthalmics   (Switzerland)

^d CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; CHYMOTRYPSIN A; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CHOROID; CILIARY BODY; CONTROLLED STUDY; ENZYME ACTIVITY; EYE; GLAUCOMA; INTRAOCULAR HYPERTENSION; IRIS; NONHUMAN; RABBIT; RECEPTOR BINDING; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION; VITREORETINOPATHY; VITREOUS BODY;

EID: 0029841850     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1996.12.299     Document Type: Article

References (53)

1. Peach, M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev., 57:313-370, 1977.
2. Schelling, P., Ganten, D., Speck, G., and Fischer, H. Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 SV3T3 cells. J. Cell. Physiol., 98:503-515, 1979.
3. Dzau, V.J., Gibbons, G.H., and Pratt, R.E. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18 (suppl II):100-105, 1991 .
4. Ray, P.E., Aguilera, G., Kopp, J.B., Horikoshi, S., and Klotman, P.E. Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int., 40:764-771, 1991.
5. Daemen, M.J.A.P., Lombardi, D.M., Bosman, F.T., and Schwartz, S.M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res., 68:450-456, 1991.
6. Stouffer, G.A. and Owens, G.K. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of TGFb. Circ. Res., 70:820-828, 1992.
7. de Gasparo, M., Bottari, S., and Levens, N.R. Characteristics of angiotensin II receptors and their role in cell and organ physiology. In Hypertension: Physiology, Diagnosis, and Management, Laragh, J.H. and Brenner, B.M., eds. Raven Press, Ltd.., New York, 1994, pp 1695-1720.
8. Fernandez, L.A., Twickler, J., and Mead, A. Neovascularization produced by angiotensin II. J. Lab. Clin. Med. 105:141-145, 1985.
9. Rakugi, H., Wang, D.S., Dzau, V.J., and Pratt, R.E. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation, 90:449-455,1994.
10. Powell, J.S., Clozel, J.P., Mueller, R.K.M., Kuhn, H., Hefti, F., and Hosang, M. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science, 245:186-188, 1989.
11. Lenoble, F.A.C., Schreurs, N.H.J.S., van Straaten, H.W.M., Slaaf, D.W., Smits, J.F.M., Roog, H., and Struijker-Boudier, H.A.J. Evidence for a novel angiotensin-II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol. 264:R460-R465, 1993.
12. Bernstein, K.E. and Alexander, R.W. Counterpoint: molecular analysis of the angiotensin II receptor. Endocr. Rev., 13:381-386, 1992.
13. Chobanian, A.V., Haudenschild, C.C., Nickerson, C., and Drago, R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15:327-331, 1990.
14. 1 receptor antagonism - a review of effects on intimai lesion formation in animal models of vascular injury, restenosis, and atherosclerosis. Drug. Develop. Res., 29:88-93, 1993.
15. Dzau, V.J. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am. J. Cardiol., 59:59A-65A, 1987.
16. Jin, M., Wilhelm, M.J., Lang, R.E., Unger, T., Lindpaintner, K., and Ganten, D. The endogenous tissue renin-angiotensin systems from molecular biology to therapy. Am. J. Med., 84 (suppl 3A):28-36, 1988.
17. Igic, R. and Kojovic, V. Angiotensin I converting enzyme (kininase II) in ocular tissues. Exp. Eye Res., 30:299-301, 1980.
18. Wallow, I.H.L., Sramek, S.J., Bindley, C.D., Darjatmoko, S.R., and Gange, S.J. Ocular renin angiotensin - EM immunocytochemical localization of prorenin. Curr. Eye Res., 12:945-950, 1993.
19. Lin, C., Stone, R.A., and Wax, M.B. Angiotensin binding sites in rabbit anterior uvea and human ciliary epithelial cells. Invest. Ophthalmol. Vis. Sci., 31:147-152, 1990.
20. Sramek, S.J., Wallow, I.H.L., Day, R.P., and Ehrlich, E.N. Ocular renin angiotensin immunohistochemical evidence for the presence of prorenin in eye tissue. Invest. Ophthalmol Vis. Sci., 29:1749-1752, 1988.
21. 8)-AII in albino rabbit ocular tissues. Curr. Eye Res., 8:841-849, 1989.
22. Ferrari-Dileo, G., Davis, E.B., and Anderson, D.R. Angiotensin binding receptors in retinal and optic nerve head blood vessels. Invest. Ophthalmol. Vis. Sci., 32:21-26, 1991.
23. Sato, T., Niwa, M., Himeno, A., Tsutsumi, K., and Amemiya, T. Quantitative receptor autoradiographic analysis for angiotensin-II receptors in bovine retinal microvessels-quantitation with radioluminography. Cell. Mol. Neurobiol., 13:233-245, 1993.
24. Danser, A.H., Derkx, F.H., Admiraal, P.J., Deinum, J., de Jong, P.T., and Schalekamp, M.A. Angiotensin levels in the eye. Invest. Ophthalmol. Vis. Sci., 35:1008-1018, 1994.
25. Brandt, C.R., Pumfery, A.M., Micales, B., Bindley, C.D., Lyons, G.E., Sramek, S.J., and Wallow, I.H. Renin mRNA is synthesized locally in rat ocular tissues. Curr. Eye Res., 13:755-763, 1994.
26. Danser, A.H., van den Dorpel, M.A., Deinum, J., Derkx, F.H.M., Franken, A.A.M., Peperkamp, E, Dejong, P.P.T.V.M., and Schalekamp, M.A.D.H. Renin, prorenin and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J. Clin. Endocrinol. Metab. 68:160-167, 1989.
27. Laliberte, M.F., Laliberte, F., Alhenc-Gelas, F., and Chevillard, C. Immunohistochemistry of angiotensin I-converting enzyme in rat eye structures involved in aqueous humor regulation. Lab. Invest., 59:263-270, 1988.
28. Watkins, R. W., Baum, T., Cedeno, K., Smith, E.M., Yuen, P.H., Ahn, H.S., and Barnett, A. Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits. J. Ocular Pharmacol., 3:295-308, 1987.
29. Al-Sereiti, M.R. and Turner, P. Effect of captopril (an angiotensin-converting enzyme inhibitor) on intraocular pressure in healthy human volunteers. J. Ocular Pharmacol., 5:1-5, 1989.
30. Constad, W.H., Fiore, P., Samson, C., and Cinotti, A.A. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am. J. Ophthalmol. 105:674-677, 1988.
31. Jackson, W.E., Holmes, D.L., Garg, S.K., Harris, S., and Chase, H.P. Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy. Ann. Ophthalmol. 24:99-103, 1992.
32. Kohner, E.M. The renin-angiotensin system and diabetic retinopathy. Klin. Wochenschr., 69 (Suppl 29):25-27, 1992.
33. Chase, H.P., Garg, S.K., Harris, S., Hoops, S., Jackson, W.E., and Holmes, D.L. Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects, a two-year trial. Ann. Ophthalmol., 25:284-289, 1993.
34. Constable, I.J. Platelet induced vitreous membrane formation. Invest. Ophthalmol. Vis. Sci., 12:680-685, 1973.
35. Anderson, D.R. Experimental alpha-chymotrypsin glaucoma studies by scanning electron microscopy. Am. J. Ophthalmol., 71:470-481, 1971.
36. Whitebread, S., Mele, M., Kamber, B., and de Gasparo, M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun., 163:284-291, 1989.
37. Menard, J. and Catt, K.J. Measurement of renin activity, concentration, and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology, 90:422-430, 1972.
38. Lieberman, J. Elevation of serum angiotensin converting enzyme (ACE) level in sarcoidosis. Am. J. Med., 59:365-370, 1975.
39. Mueller, P., Cohen, T., de Gasparo, M., Sioufi, A., Racine Poon, A., and Howald, H. Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. Eur. J. Clin. Pharmacol. 47:231-245, 1994.
40. 2+ activated aspartate aminopeptidase activity, subcellular localization in young and adult rat brain. Brain Res., 522:165-167, 1990.
41. Jurklies, B., Kohler, K., Eikermann, J., and Zrenner, E. Angiotensin II-like immunoreactivity in the retina of some mammalian species. Ger. J. Ophthalmol., 3:37-42, 1994.
42. Bleuel, A., de Gasparo, M., Whitebread, S., Puttner, I., and Monard, D. Regulation of protease nexin-1 expression in cultured schwann cells is mediated by angiotensin-II receptors. J. Neurosci, 15:750-761, 1995.
43. Sumners, C., Tang, W., Zelezna, B., and Raizada, M.K. Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc. Natl. Acad. Sci. USA, 88:7567-7571, 1991.
44. 2) in rat brain. Am. J. Physiol., 261:R209-R216, 1991.
45. Mallorga, P., Whiffield, M., and Sugrue, M.F. Angiotensin receptor subtypes in the albino rabbit eye. Soc. Neurosci. Abstr.,17:810, 1991.
46. 2 isoforms of the angiotensin receptor mediates myointimal hyperplasia following vascular injury. Hypertension 20:432, 1992.
47. de Gasparo, M., Rogg, H., Brink, M., Wang, L., Whitebread, S., Bullock, G., and Erne, P. Angiotensin II receptor subtypes and cardiac function. Eur. Heart J., 15 (suppl D):98-103, 1994.
48. Grady, E.F., Sechi, L.A., Griffin, C.A., Schambelan, M., and Kalinyak, J.E. Expression of AT-2 receptors in the developing rat fetus. J. Clin. Invest., 88:921-933, 1991.
49. Janiak, P., Pillon, A., Prost, J.F., and Vilaine, J.P. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension, 20:737-745, 1992.
50. Viswanathan, M. and Saavedra, J.M. Expression of angiotensin-II AT(2) receptors in the rat skin during experimental wound healing. Peptides, 13:783-786, 1992.
51. Stoll, M., Steckelings, U.M., Paul, M., Bottari, S.P., Metzger, R., and Unger, T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest., 95:651-657, 1995.
52. Yamada, T., Horiuchi, M., and Dzau, V.J. Angiotensin II type 2 receptor mediated programmed cell death. Proc. Natl. Acad. Sci., USA, 93:156-160, 1996.
53. Lo, M., Liu, K.L., Lanteime, P, and Sassard, J. Subtype 2 of angiotensin II receptors controls pressure natriuresis in rats. J. Clin. Invest., 95:1394-1397, 1995.